Evexia Lifecare Ltd: Share Price Analysis, Intrinsic Value & Fundamentals (2025)

Share Price and Basic Stock Data

Last Updated: February 24, 2025, 12:20 pm

Market Cap	505 Cr.
Current Price	2.69
High / Low	4.40/1.94
Stock P/E	134
Book Value	1.80
Dividend Yield	0.00 %
ROCE	0.30 %
ROE	1.26 %
Face Value	1.00
PEG Ratio	-10.35

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Evexia Lifecare Ltd

Competitors of Evexia Lifecare Ltd

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
IEL Ltd	84.8 Cr.	6.35	8.71/3.36	107	0.13	0.00 %	17.5 %	23.6 %	1.00
Evexia Lifecare Ltd	505 Cr.	2.69	4.40/1.94	134	1.80	0.00 %	0.30 %	1.26 %	1.00
Diligent Industries Ltd	43.6 Cr.	1.83	6.29/1.74	15.2	0.83	0.00 %	7.35 %	12.0 %	1.00
CIAN Agro Industries & Infrastructure Ltd	1,139 Cr.	407	540/36.1	218	31.9	0.00 %	11.1 %	5.85 %	10.0
BCL Industries Ltd	1,134 Cr.	38.4	81.4/34.5	12.2	25.6	0.64 %	15.7 %	16.0 %	1.00
Industry Average	9,907.69 Cr	114.87		52.05	28.27	0.21%	11.32%	10.26%	4.33

All Competitor Stocks of Evexia Lifecare Ltd

Quarterly Result

Metric	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
Sales	26.03	12.44	20.01	13.80	12.41	18.57	24.78	14.02	10.65	6.90	24.72	21.23	27.97
Expenses	25.43	11.83	19.24	14.18	11.86	18.02	24.92	13.83	12.01	6.81	21.66	20.93	26.88
Operating Profit	0.60	0.61	0.77	-0.38	0.55	0.55	-0.14	0.19	-1.36	0.09	3.06	0.30	1.09
OPM %	2.31%	4.90%	3.85%	-2.75%	4.43%	2.96%	-0.56%	1.36%	-12.77%	1.30%	12.38%	1.41%	3.90%
Other Income	0.03	-0.00	0.01	0.49	0.35	0.86	0.18	0.20	-0.20	-0.00	0.86	0.13	0.05
Interest	-0.00	-0.00	0.08	0.01	0.15	-0.14	0.52	-0.00	0.01	-0.00	0.49	-0.00	0.05
Depreciation	0.03	0.06	0.04	0.09	0.10	0.10	0.10	0.10	0.10	0.07	0.15	0.10	0.11
Profit before tax	0.60	0.55	0.66	0.01	0.65	1.45	-0.58	0.29	-1.67	0.02	3.28	0.33	0.98
Tax %	25.00%	25.45%	142.42%	-0.00%	56.92%	26.21%	41.38%	27.59%	-0.00%	50.00%	16.77%	24.24%	26.53%
Net Profit	0.45	0.41	-0.27	0.01	0.29	1.07	-0.83	0.22	-1.67	0.01	2.73	0.24	0.73
EPS in Rs	0.01	0.01	-0.00	0.00	0.00	0.02	-0.01	0.00	-0.03	0.00	0.04	0.00	0.01

Last Updated: January 5, 2025, 8:10 am

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: Unknown

Metric	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM
Sales	0.62	33.96	177.53	74.10	105.42	100.20	106.63	75.51	69.55	56.29	63.50
Expenses	0.67	34.07	176.26	74.45	106.31	106.51	178.81	73.10	68.97	54.32	61.41
Operating Profit	-0.05	-0.11	1.27	-0.35	-0.89	-6.31	-72.18	2.41	0.58	1.97	2.09
OPM %	-8.06%	-0.32%	0.72%	-0.47%	-0.84%	-6.30%	-67.69%	3.19%	0.83%	3.50%	3.29%
Other Income	0.43	0.51	0.16	1.27	3.48	11.72	74.35	0.07	1.88	0.87	0.79
Interest	0.02	0.05	0.02	0.02	0.02	0.21	0.01	0.10	0.54	0.49	0.50
Depreciation	0.20	0.08	0.08	0.18	0.32	0.31	0.24	0.21	0.39	0.42	0.42
Profit before tax	0.16	0.27	1.33	0.72	2.25	4.89	1.92	2.17	1.53	1.93	1.96
Tax %	31.25%	40.74%	32.33%	33.33%	30.22%	29.24%	33.33%	60.37%	56.21%	28.50%
Net Profit	0.11	0.16	0.90	0.48	1.57	3.47	1.28	0.86	0.67	1.38	1.28
EPS in Rs	0.00	0.00	0.01	0.01	0.03	0.06	0.02	0.01	0.01	0.02	0.01
Dividend Payout %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2015-2016	2016-2017	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024
YoY Net Profit Growth (%)	45.45%	462.50%	-46.67%	227.08%	121.02%	-63.11%	-32.81%	-22.09%	105.97%
Change in YoY Net Profit Growth (%)	0.00%	417.05%	-509.17%	273.75%	-106.06%	-184.13%	30.30%	10.72%	128.06%

Evexia Lifecare Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 9 years from 2015-2016 to 2023-2024.

Growth

Compounded Sales Growth
10 Years:	%
5 Years:	-12%
3 Years:	-19%
TTM:	68%

Compounded Profit Growth
10 Years:	%
5 Years:	-3%
3 Years:	2%
TTM:	262%

Stock Price CAGR
10 Years:	13%
5 Years:	-25%
3 Years:	-9%
1 Year:	12%

Return on Equity
10 Years:	%
5 Years:	2%
3 Years:	1%
Last Year:	1%

Last Updated: Unknown

Balance Sheet

Last Updated: December 14, 2024, 1:44 pm

Month	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Sep 2024
Equity Capital	46.46	61.93	61.93	61.93	61.93	61.93	61.93	61.93	66.44	70.80	142.03
Reserves	19.29	3.42	3.84	11.33	12.91	16.41	17.67	18.52	24.05	58.59	195.12
Borrowings	4.66	10.78	6.01	6.22	4.12	7.12	6.78	5.79	704.85	686.16	502.07
Other Liabilities	3.59	35.47	147.02	128.46	145.51	138.58	55.79	40.83	52.16	67.45	77.66
Total Liabilities	74.00	111.60	218.80	207.94	224.47	224.04	142.17	127.07	847.50	883.00	916.88
Fixed Assets	2.40	2.28	2.30	8.90	8.62	8.94	8.84	8.96	10.98	10.72	10.63
CWIP	0.02	0.20	0.20	0.00	0.00	0.00	0.00	2.16	0.03	0.03	0.03
Investments	3.55	0.51	0.52	0.01	0.01	0.01	0.87	0.87	704.36	723.79	748.84
Other Assets	68.03	108.61	215.78	199.03	215.84	215.09	132.46	115.08	132.13	148.46	157.38
Total Assets	74.00	111.60	218.80	207.94	224.47	224.04	142.17	127.07	847.50	883.00	916.88

Reserves and Borrowings Chart

Cash Flow

Month	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Cash from Operating Activity +	4.10	10.85	-116.14	-11.75	-0.26	-2.58	1.71	-5.74	-3.15	17.02
Cash from Investing Activity +	0.22	2.33	0.55	-5.92	0.02	0.54	-2.43	7.72	-696.62	-17.31
Cash from Financing Activity +	-3.64	-12.28	113.19	17.63	0.42	1.59	0.77	-0.95	698.70	0.56
Net Cash Flow	0.68	0.91	-2.39	-0.03	0.17	-0.46	0.05	1.03	-1.07	0.28

Free Cash Flow

Month	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Free Cash Flow	-4.71	-10.89	-4.74	-6.57	-5.01	-13.43	-78.96	-3.38	-704.27	-684.19

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	983.15	237.10	286.42	173.58	197.42	248.76	156.37	73.28	164.47	282.43
Inventory Days	197.30	4.70	1.64	3.03	2.98	2.27	11.70	6.96	11.18	8.00
Days Payable	187.43	383.91	73.29	67.30	158.16	171.51	114.48	124.30	186.39	194.93
Cash Conversion Cycle	993.01	-142.11	214.77	109.31	42.23	79.52	53.58	-44.05	-10.74	95.49
Working Capital Days	-1,577.74	248.17	250.48	277.72	133.78	266.46	215.10	203.21	254.11	404.83
ROCE %		0.44%	1.83%	0.98%	2.86%	6.20%	2.30%	2.63%	0.47%	0.30%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Promoters	43.02%	15.12%	13.00%	10.59%	9.87%	9.87%	9.87%	9.87%	9.26%	6.29%	5.87%	3.49%
FIIs	1.47%	0.00%	0.00%	0.00%	6.79%	3.36%	3.36%	1.43%	0.00%	1.03%	1.49%	0.16%
DIIs	0.31%	0.31%	0.31%	0.31%	0.28%	0.28%	0.28%	0.28%	0.27%	0.17%	0.17%	0.09%
Public	55.20%	84.58%	86.70%	89.12%	83.08%	86.49%	86.48%	88.42%	90.47%	92.50%	92.48%	96.25%
No. of Shareholders	1,00,353	1,25,166	1,27,293	1,24,466	1,20,874	1,13,942	1,17,029	1,19,026	1,35,145	1,28,850	1,31,843	1,52,296

Shareholding Pattern Chart

No. of Shareholders

This stock is not held by any mutual fund

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
FaceValue	1.00	1.00	2.00	10.00	10.00
Basic EPS (Rs.)	0.02	0.01	0.03	0.21	0.56
Diluted EPS (Rs.)	0.02	0.01	0.03	0.21	0.56
Cash EPS (Rs.)	0.02	0.01	0.03	0.24	0.61
Book Value[Excl.RevalReserv]/Share (Rs.)	1.83	1.25	2.37	11.72	11.52
Book Value[Incl.RevalReserv]/Share (Rs.)	1.83	1.36	2.60	12.86	12.65
Revenue From Operations / Share (Rs.)	0.79	1.05	2.44	17.22	16.18
PBDIT / Share (Rs.)	0.04	0.03	0.08	0.35	0.87
PBIT / Share (Rs.)	0.03	0.03	0.07	0.31	0.82
PBT / Share (Rs.)	0.02	0.02	0.07	0.31	0.79
Net Profit / Share (Rs.)	0.01	0.01	0.02	0.20	0.56
NP After MI And SOA / Share (Rs.)	0.01	0.01	0.02	0.20	0.56
PBDIT Margin (%)	5.04	3.54	3.28	2.04	5.40
PBIT Margin (%)	4.30	2.97	3.01	1.81	5.09
PBT Margin (%)	3.42	2.19	2.88	1.80	4.88
Net Profit Margin (%)	2.44	0.95	1.14	1.20	3.46
NP After MI And SOA Margin (%)	2.44	0.95	1.14	1.20	3.46
Return on Networth / Equity (%)	1.06	0.79	1.17	1.76	4.86
Return on Capital Employeed (%)	0.28	0.25	2.36	2.12	3.13
Return On Assets (%)	0.15	0.07	0.67	0.89	1.54
Long Term Debt / Equity (X)	5.23	8.34	0.00	0.01	0.01
Total Debt / Equity (X)	5.30	8.45	0.07	0.10	0.09
Asset Turnover Ratio (%)	0.06	0.14	0.53	0.27	0.43
Current Ratio (X)	2.23	1.86	2.67	2.10	2.11
Quick Ratio (X)	2.21	1.82	2.63	2.04	2.10
Inventory Turnover Ratio (X)	1.24	0.62	0.41	2.17	2.40
Interest Coverage Ratio (X)	5.77	4.56	24.67	182.81	25.91
Interest Coverage Ratio (Post Tax) (X)	3.80	2.23	9.56	108.78	17.61
Enterprise Value (Cr.)	858.94	812.50	182.67	916.31	521.35
EV / Net Operating Revenue (X)	15.26	11.68	2.42	8.59	5.20
EV / EBITDA (X)	302.72	329.87	73.54	421.22	96.32
MarketCap / Net Operating Revenue (X)	3.08	1.56	2.36	8.52	5.14
Price / BV (X)	1.34	1.30	2.43	12.53	7.22
Price / Net Operating Revenue (X)	3.08	1.56	2.36	8.52	5.14
EarningsYield	0.01	0.01	0.00	0.00	0.01

After reviewing the key financial ratios for Evexia Lifecare Ltd, here is a detailed analysis based on the latest available data and recent trends:

For FaceValue, as of Mar 24, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 1.00.
For Basic EPS (Rs.), as of Mar 24, the value is 0.02. This value is below the healthy minimum of 5. It has increased from 0.01 (Mar 23) to 0.02, marking an increase of 0.01.
For Diluted EPS (Rs.), as of Mar 24, the value is 0.02. This value is below the healthy minimum of 5. It has increased from 0.01 (Mar 23) to 0.02, marking an increase of 0.01.
For Cash EPS (Rs.), as of Mar 24, the value is 0.02. This value is below the healthy minimum of 3. It has increased from 0.01 (Mar 23) to 0.02, marking an increase of 0.01.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 1.83. It has increased from 1.25 (Mar 23) to 1.83, marking an increase of 0.58.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 1.83. It has increased from 1.36 (Mar 23) to 1.83, marking an increase of 0.47.
For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 0.79. It has decreased from 1.05 (Mar 23) to 0.79, marking a decrease of 0.26.
For PBDIT / Share (Rs.), as of Mar 24, the value is 0.04. This value is below the healthy minimum of 2. It has increased from 0.03 (Mar 23) to 0.04, marking an increase of 0.01.
For PBIT / Share (Rs.), as of Mar 24, the value is 0.03. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 0.03.
For PBT / Share (Rs.), as of Mar 24, the value is 0.02. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 0.02.
For Net Profit / Share (Rs.), as of Mar 24, the value is 0.01. This value is below the healthy minimum of 2. There is no change compared to the previous period (Mar 23) which recorded 0.01.
For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 0.01. This value is below the healthy minimum of 2. There is no change compared to the previous period (Mar 23) which recorded 0.01.
For PBDIT Margin (%), as of Mar 24, the value is 5.04. This value is below the healthy minimum of 10. It has increased from 3.54 (Mar 23) to 5.04, marking an increase of 1.50.
For PBIT Margin (%), as of Mar 24, the value is 4.30. This value is below the healthy minimum of 10. It has increased from 2.97 (Mar 23) to 4.30, marking an increase of 1.33.
For PBT Margin (%), as of Mar 24, the value is 3.42. This value is below the healthy minimum of 10. It has increased from 2.19 (Mar 23) to 3.42, marking an increase of 1.23.
For Net Profit Margin (%), as of Mar 24, the value is 2.44. This value is below the healthy minimum of 5. It has increased from 0.95 (Mar 23) to 2.44, marking an increase of 1.49.
For NP After MI And SOA Margin (%), as of Mar 24, the value is 2.44. This value is below the healthy minimum of 8. It has increased from 0.95 (Mar 23) to 2.44, marking an increase of 1.49.
For Return on Networth / Equity (%), as of Mar 24, the value is 1.06. This value is below the healthy minimum of 15. It has increased from 0.79 (Mar 23) to 1.06, marking an increase of 0.27.
For Return on Capital Employeed (%), as of Mar 24, the value is 0.28. This value is below the healthy minimum of 10. It has increased from 0.25 (Mar 23) to 0.28, marking an increase of 0.03.
For Return On Assets (%), as of Mar 24, the value is 0.15. This value is below the healthy minimum of 5. It has increased from 0.07 (Mar 23) to 0.15, marking an increase of 0.08.
For Long Term Debt / Equity (X), as of Mar 24, the value is 5.23. This value exceeds the healthy maximum of 1. It has decreased from 8.34 (Mar 23) to 5.23, marking a decrease of 3.11.
For Total Debt / Equity (X), as of Mar 24, the value is 5.30. This value exceeds the healthy maximum of 1. It has decreased from 8.45 (Mar 23) to 5.30, marking a decrease of 3.15.
For Asset Turnover Ratio (%), as of Mar 24, the value is 0.06. It has decreased from 0.14 (Mar 23) to 0.06, marking a decrease of 0.08.
For Current Ratio (X), as of Mar 24, the value is 2.23. This value is within the healthy range. It has increased from 1.86 (Mar 23) to 2.23, marking an increase of 0.37.
For Quick Ratio (X), as of Mar 24, the value is 2.21. This value exceeds the healthy maximum of 2. It has increased from 1.82 (Mar 23) to 2.21, marking an increase of 0.39.
For Inventory Turnover Ratio (X), as of Mar 24, the value is 1.24. This value is below the healthy minimum of 4. It has increased from 0.62 (Mar 23) to 1.24, marking an increase of 0.62.
For Interest Coverage Ratio (X), as of Mar 24, the value is 5.77. This value is within the healthy range. It has increased from 4.56 (Mar 23) to 5.77, marking an increase of 1.21.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 3.80. This value is within the healthy range. It has increased from 2.23 (Mar 23) to 3.80, marking an increase of 1.57.
For Enterprise Value (Cr.), as of Mar 24, the value is 858.94. It has increased from 812.50 (Mar 23) to 858.94, marking an increase of 46.44.
For EV / Net Operating Revenue (X), as of Mar 24, the value is 15.26. This value exceeds the healthy maximum of 3. It has increased from 11.68 (Mar 23) to 15.26, marking an increase of 3.58.
For EV / EBITDA (X), as of Mar 24, the value is 302.72. This value exceeds the healthy maximum of 15. It has decreased from 329.87 (Mar 23) to 302.72, marking a decrease of 27.15.
For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 3.08. This value exceeds the healthy maximum of 3. It has increased from 1.56 (Mar 23) to 3.08, marking an increase of 1.52.
For Price / BV (X), as of Mar 24, the value is 1.34. This value is within the healthy range. It has increased from 1.30 (Mar 23) to 1.34, marking an increase of 0.04.
For Price / Net Operating Revenue (X), as of Mar 24, the value is 3.08. This value exceeds the healthy maximum of 3. It has increased from 1.56 (Mar 23) to 3.08, marking an increase of 1.52.
For EarningsYield, as of Mar 24, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 23) which recorded 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation. If you have any questions or need more detailed insights, please feel free to reach out.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Evexia Lifecare Ltd as of February 24, 2025 is: ₹2.48

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of February 24, 2025, Evexia Lifecare Ltd is Overvalued by 7.81% compared to the current share price ₹2.69

Intrinsic Value of Evexia Lifecare Ltd as of February 24, 2025 is: 2.16

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of February 24, 2025, Evexia Lifecare Ltd is Overvalued by 19.70% compared to the current share price ₹2.69

Last 5 Year EPS CAGR: -12.94%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The stock is trading at a low valuation with an average P/B ratio of 0.25 and average Dividend Yield of 3.44%. The company has shown consistent growth in sales (78.48 cr) and profit (1.74 cr) over the years.	The stock has a low average ROCE of 1.80%, which may not be favorable. The stock has a high average Working Capital Days of 225.29, which may not be favorable. The stock has a high average Cash Conversion Cycle of 139.10, which may not be favorable. The company has higher borrowings (176.78) compared to reserves (34.65), which may suggest financial risk.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Evexia Lifecare Ltd:
1. Net Profit Margin: 2.44%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 0.28% (Industry Average ROCE: 11.32%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 1.06% (Industry Average ROE: 9.77%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 3.8
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 2.21
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 134 (Industry average Stock P/E: 39.66)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 5.3
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

Evexia Lifecare Ltd. is a Public Limited Listed company incorporated on 23/11/1990 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L23100GJ1990PLC014692 and registration number is 014692. Currently company belongs to the Industry of Edible Oils & Solvent Extraction. Company's Total Operating Revenue is Rs. 54.90 Cr. and Equity Capital is Rs. 70.80 Cr. for the Year ended 31/03/2024.

INDUSTRY	ADDRESS	CONTACT
Edible Oils & Solvent Extraction	Tundav Anjesar Road, Village Tundav, Ta. Savli, Vadodra Gujarat 391775	info@evexialifecare.com http://www.evexialifecare.com

Management
Name	Position Held
Mr. Jayesh R Thakkar	Chairman & Managing Director
Mr. Hasmukh D Thakkar	Non Exe.Non Ind.Director
Ms. Payal Gajjar	Ind. Non-Executive Director
Mr. Mohammadraza Makrani	Ind. Non-Executive Director
Mr. Kartik B Mistry	Ind. Non-Executive Director
Mr. Parth Patel	Ind. Non-Executive Director

FAQ

What is the latest intrinsic value of Evexia Lifecare Ltd?

Let's break down Evexia Lifecare Ltd's intrinsic value simply:

We calculate intrinsic value using the PE Ratio Method - comparing the company's current price-to-earnings ratio with its historical average and industry peers. Think of it like checking if a stock is "on sale" compared to its typical pricing.

As of 24 February 2025:

Calculated Fair Value: ₹2.48
Current Market Price: ₹2.69
Variance: 7.81% lower

This suggests Evexia Lifecare Ltd is currently overvalued by 7.81%. For context:

Market Cap: 505 Cr.
52-Week Range: 4.40/1.94
Reserves (Sep 2024): ₹195.12 Cr
Liabilities: 916.88 Cr

Remember: The PE method gives a snapshot based on earnings multiples. While useful for quick comparisons, investors should also consider growth prospects, industry trends, and economic conditions. This calculation assumes historical PE ratios remain relevant - always verify with current market dynamics.

What is the Market Cap of Evexia Lifecare Ltd?

The Market Cap of Evexia Lifecare Ltd is 505 Cr..

What is the current Stock Price of Evexia Lifecare Ltd as on 24 February 2025?

The current stock price of Evexia Lifecare Ltd as on 24 February 2025 is ₹2.69.

What is the High / Low of Evexia Lifecare Ltd stocks in FY 2024-2025?

In FY 2024-2025, the High / Low of Evexia Lifecare Ltd stocks is 4.40/1.94.

What is the Stock P/E of Evexia Lifecare Ltd?

The Stock P/E of Evexia Lifecare Ltd is 134.

What is the Book Value of Evexia Lifecare Ltd?

The Book Value of Evexia Lifecare Ltd is 1.80.

What is the Dividend Yield of Evexia Lifecare Ltd?

The Dividend Yield of Evexia Lifecare Ltd is 0.00 %.

What is the ROCE of Evexia Lifecare Ltd?

The ROCE of Evexia Lifecare Ltd is 0.30 %.

What is the ROE of Evexia Lifecare Ltd?

The ROE of Evexia Lifecare Ltd is 1.26 %.

What is the Face Value of Evexia Lifecare Ltd?

The Face Value of Evexia Lifecare Ltd is 1.00.